Expression of phospholipid biosynthetic genes in yeast requires activator protein Ino2 which can bind to the UAS element inositol/choline-responsive element (ICRE) and trigger activation of target genes, using two separate transcriptional activation domains, TAD1 and TAD2. However, it is still unknown which cofactors mediate activation by TADs of Ino2. Here, we show that multiple subunits of basal transcription factor TFIID (TBP-associated factors Taf1, Taf4, Taf6, Taf10 and Taf12) are able to interact in vitro with activation domains of Ino2. Interaction was no longer observed with activationdefective variants of TAD1. We were able to identify two nonoverlapping regions in the N-terminus of Taf1 (aa 1-100 and aa 182-250) each of which could interact with TAD1 of Ino2 as well as with TAD4 of activator Adr1. Specific missense mutations within Taf1 domain aa 182-250 affecting basic and hydrophobic residues prevented interaction with wild-type TAD1 and caused reduced expression of INO1. Using chromatin immunoprecipitation we demonstrated Ino2-dependent recruitment of Taf1 and Taf6 to ICREcontaining promoters INO1 and CHO2. Transcriptional derepression of INO1 was no longer possible with temperature-sensitive taf1 and taf6 mutants cultivated under nonpermissive conditions. This result supports the hypothesis of Taf-dependent expression of structural genes activated by Ino2.
Introduction
For expression of yeast structural genes of phospholipid biosynthesis (such as INO1, CHO1, CHO2, FAS1 and FAS2), a specific upstream sequence motif, designated ICRE (inositol/choline-responsive element, Sch€ uller et al., 1992a; 5 UAS INO , Lopes et al., 1991) is required. ICRE motifs are bound by a heterodimer which consists of regulatory proteins Ino2 and Ino4, both containing a basic helix-loop-helix (bHLH) structural motif essential for DNA recognition (Sch€ uller et al., 1992b; Ambroziak and Henry, 1994; Schwank et al., 1995) . While Ino4 is responsible for nuclear import of the heterodimer (Kumme et al., 2008) , gene activation is mediated exclusively by Ino2 and its transcriptional activation domains, TAD1 (aa 1-35) and TAD2 (aa 101-135; Schwank et al., 1995; Dietz et al., 2003) . Mutational analysis of the more effective TAD1 at amino acid positions strictly conserved among Saccharomyces yeasts revealed the importance of acidic and bulky hydrophobic residues (Dietz et al., 2003) .
Two major mechanisms contribute to transcriptional activation in eukaryotes: (I) increased access to DNA by modifying its chromatin organization (covalent modification of histones or nucleosome dynamics by chromatin remodelling complexes); (II) improved recruitment of general transcription factors to basal promoters, accelerating formation of the preinitiation complex (PIC) and efficiency of RNA synthesis (for a review focusing on yeast see Hahn and Young, 2011) . For maximal gene activation by Ino2, the catalytic subunit Gcn5 of the histone acetyltransferase complex SAGA and several subunits of the mediator complex are required (Dietz et al., 2003; Dettmann et al., 2010) . However, it was not possible to demonstrate physical contact of Ino2 TADs with subunits of mediator while basal transcription factor TFIIB (Sua7 in yeast) and histone methyltransferase Set2 could bind to the bHLH domain of Ino2. SAGAdependency of Ino2 function is indirectly mediated by recruitment of the pleiotropic Snf1 protein kinase complex by Ino2 TADs. Snf1 acts as a histone kinase, phosphorylating H3 at its Ser10 residue which then allows binding of SAGA to pSer10-modified chromatin by an unknown pathway (Lo et al., 2005) . In agreement with these findings, a snf1 null mutant showed growth retardation in the absence of inositol and Ino2-dependent transcription was reduced to about 36% of the wild-type level (Dettmann et al., 2010) . Nevertheless, additional mechanisms of activation must exist for gene activation by Ino2.
In addition to SAGA, the general transcription factor TFIID has a fundamental function for transcriptional control . TFIID contains the TATA-box binding protein TBP and 13 or 14 TBP-associated factors (in yeast: Taf1-Taf14) which together mediate multiple contacts to core promoter sequences (Papai et al., 2011) , thus providing the scaffold for subsequent PIC assembly. Cryo-EM studies of purified TFIID showed that the complex adopts an asymmetric horseshoe-like shape with three separate lobes (Papai et al., 2009; Bieniossek et al., 2013; Louder et al., 2016) . A sequence motif resembling a-helical structures in histones has been identified in nine Taf proteins (histone-fold domain, HFD; Gangloff et al., 2001a) , allowing the formation of heterodimeric Taf subcomplexes (Taf3-Taf10, Taf6-Taf9, Taf4-Taf12, Taf8-Taf10 and Taf11-Taf13). Importantly, several Taf subunits of TFIID also constitute a subcomplex within SAGA (Taf5, Taf6, Taf9, Taf10 and Taf12; Grant et al., 1998) , indicating a possible cross-talk and functional redundancy of both complexes. Although yeast TAF genes are essential for viability (exception: TAF14), not all structural genes require the complete set of Taf proteins for transcriptional initiation. While TBP could be detected at all promoters tested, occupancy by Tafs was highly promoter selective (Kuras et al., 2000; Li et al., 2000) . Using mutants which encode temperaturesensitive Taf variants it could be shown that transcription of certain promoters was clearly Taf-dependent while others were still effective even in the presence of nonfunctional Taf proteins. A more comprehensive analysis revealed that certain promoters depend on some but not all Taf proteins (Shen et al., 2003) . Genome-wide studies led to the conclusion that most TFIID/Taf-dependent genes are weakly regulated and support house-keeping functions while SAGA-dependent genes show strong regulation by nutrient availability and cellular stress (Huisinga and Pugh, 2004) . Thus, promoter recruitment of the indispensable TBP may be achieved either by Taf subunits of TFIID or by SAGA, presumably via its subunit Spt3 (Larschan and Winston, 2001 ).
Investigations on target factors which are contacted by TADs mainly focused on activators such as Gal4, Gcn4 and VP16 for which at least 10 distinct interaction partners could be identified (reviewed by Bhaumik, 2011) . Although activation of the Ino2-dependent INO1 gene is highly sensitive against perturbations of the general transcriptional machinery (e.g., missense mutations within TBP/Spt15 or truncation of the C-terminal domain of RNA polymerase II subunit Rpb1) (Scafe et al., 1990; Arndt et al., 1995) interaction partners of  Ino2 activation domains TAD1 and/or TAD2 (besides  Snf1) have not yet been described. In this work we show that activation domains of Ino2 are able to bind directly to five Taf subunits of TFIID and that basic and hydrophobic amino acids within Tafs play a major role for these interactions. We also demonstrate Ino2-dependent recruitment of Tafs to ICRE-containing promoters and the importance of Tafs for activation of the highly regulated INO1 gene.
Results

Transcriptional activator Ino2 interacts with Taf subunits of TFIID
Using affinity chromatography (GST pull-down) we have previously shown that yeast activator Ino2 is able to directly interact with general transcription factor TFIIB (5 Sua7; Dietz et al., 2003) and histone methyltransferase Set2 (Dettmann et al., 2010) via its C-terminal helix-loop-helix domain. However, it remained unclear which proteins mediate increased transcription of ICREdependent genes by binding to Ino2 N-terminal activation domains TAD1 and TAD2. Since yeast promoters can be classified according to their differential dependence on Taf subunits of basal transcription factor TFIID (Kuras et al., 2000; Li et al., 2000) we systematically investigated whether Ino2 is able to interact with Taf proteins. HA-tagged variants of all Taf proteins were synthesized by using yeast multicopy expression plasmids containing the entire coding regions of TAF genes (exception: HA-Taf3 and HA-Taf13 were produced in bacteria because we could not detect labelled variants of these proteins in extracts of yeast transformants). A GST-Ino2 fusion representing full-length Ino2 was incubated with protein extracts each containing a single epitope-tagged Taf protein. TBP (TATA-box binding protein, Spt15) as the remaining subunit of TFIID was not used for these experiments since we could previously show that it is not a binding partner of Ino2 (Dietz et al., 2003) . Experimental conditions of incubation and stringency of subsequent washing were identical to previous studies demonstrating interaction of Ino2 with Sua7 and Set2 (Dietz et al., 2003; Dettmann et al., 2010) . As is shown in Fig. 1 , Ino2 could indeed bind to Taf1, Taf4, Taf5, Taf6, Taf10 and Taf12. No interaction signals were obtained with extracts containing the remaining eight Taf subunits of TFIID.
Since protein extracts prepared from yeast transformants have been used to demonstrate Ino2-Taf interactions, we cannot exclude that at least some signals are the result of an indirect binding to Ino2, depending on Taf-Taf subcomplexes within TFIID (Papai et al., 2011) . For the six Taf proteins which could interact with Ino2 we, thus, repeated binding studies using HA-Taf fusions synthesized bacterially. Results depicted in Fig. 2 confirm that Taf1, Taf4, Taf6, Taf10 and Taf12 are indeed able to interact with Ino2 even in the absence of additional yeast proteins. Since we did not obtain an interaction signal with HA-Taf5 from E. coli, binding of Ino2 to Taf5 must be considered as indirect. Consequently, Taf5 was no longer investigated in subsequent studies.
Taf proteins interact with Ino2 activation domains TAD1 and TAD2
Having shown direct contact of full-length Ino2 with Taf proteins we next wished to identify the domains of Ino2 being responsible for this interaction. We, thus, constructed GST fusion plasmids which allow the biosynthesis of Ino2 length variants, including individual transcriptional activation domains TAD1 (aa 1-35) and TAD2 (aa 101-135). Indeed, the N-terminus of Ino2 (aa 1-135) containing TAD1 and TAD2 was able to interact with Taf1, Taf4, Taf6, Taf10 and Taf12. Moreover, all of these Taf proteins could also bind to the strong TAD1 while the less efficient TAD2 bound only to Taf10 (Fig. 3) . It should be mentioned that we also observed interaction of Taf4 with the C-terminus of Ino2 containing its bHLH domain.
We have previously shown that missense mutations D20K and F21R completely abolished gene activation by Ino2 TAD1 (Dietz et al., 2003) . To investigate whether these TAD1 variants influence binding to Taf proteins, GST fusions containing wild-type TAD1 (aa 1-35) or its mutant variants D20K and F21R were incubated with Full-length fusion protein GST-Ino2 (encoded by pSS56) was immobilized on GSH sepharose and incubated with protein extracts from E. coli containing selected epitope-tagged Taf proteins. HA-Taf fusion proteins are encoded by bacterial expression plasmids pSH115 (TAF1 1-250 ), pMS5 (TAF4), pSH151 (TAF5), pSH150 (TAF6), pMS7 (TAF10) and pMS8 (TAF12), each containing the tetracyclin-inducible tet P/Op -control region. Crude extracts containing 30 mg of total protein were used for the interaction experiments. HA-Taf input controls are shown in the left lanes. Binding assays with GST served as negative controls (middle lanes) while interaction experiments with the GST-Ino2 fusion are depicted in the right lanes. Fig. 1 . Transcriptional activator Ino2 interacts with several Taf subunits of TFIID.
Full-length fusion protein GST-Ino2 (encoded by pSS56) was immobilized on GSH sepharose and incubated with protein extracts from S. cerevisiae or E. coli containing epitope-tagged Taf proteins. MET25-containing multicopy expression plasmids pSH105 (TAF1), pSH126 (TAF2), pMS1 (TAF4), pEW2 (TAF5), pEW1 (TAF6), pSH133 (TAF7), pSH139 (TAF8), pDS2 (TAF9), pMS3 (TAF10), pDS3 (TAF11), pMS4 (TAF12) and pDS4 (TAF14) encoding HA 3 fusion proteins were individually transformed into yeast strain C13-ABY.S86. Crude extracts containing 50 mg of total yeast protein were used for the interaction experiments. HA-Taf3 and HA-Taf13 fusion proteins are encoded by E. coli expression plasmids pSH159 and pSH160, respectively, each containing the tetracyclin-inducible tet P/Op -control region. For the interaction experiments, crude bacterial extracts containing 30 mg of total protein were used. HA-Taf input controls are shown in the left lanes. Binding assays with GST served as negative controls (middle lanes) while interaction experiments with the GST-Ino2 fusion are depicted in the right lanes.
yeast protein extracts each containing a single HA-Taf protein. Importantly, none of the five Tafs being able to directly interact with wild-type TAD1 could bind to mutant TAD1 (Fig. 4) . We conclude that D20 and F21 are similarly important for binding of TAD1 to the Taf proteins tested, providing a plausible explanation why these variants showed total loss of gene activation.
Identification of two activator binding domains within Taf1
Taf1 is a multidomain protein which has been described as a transcriptional toolbox (Wassarman and Sauer, 2001) , involved in structural organization of TFIID (domains TAND and Taf-Taf; cf. Fig. 5 ), promoter binding (DBD and WH) and possibly histone acetylation (HAT). We, thus, asked which sequence within Taf1 is responsible for binding to Ino2 TAD1. Epitope-tagged length variants of Taf1 which could be stably synthesized either in S. cerevisiae or in E. coli were used for assaying interaction with GST-fused TAD1 of Ino2. Results summarized in Fig. 5 show that Ino2 TAD1 is able to bind to aa 1-100 of Taf1 comprising its complete TAND subdomains 1 and 2 (Taf1 N-terminal domain) while TAND3 is truncated. TANDs possess a negativeregulatory role as they can bind to the concave (TAND1, TAND3) and convex sides of TBP (TAND2), respectively, thereby preventing recognition of the TATA-box and counteracting access of TBP to the basal promoter (Mal et al., 2004) . In contrast, this auto-inhibition within the TFIID complex can be relieved by activator binding to TANDs, leading to release of TBP and subsequent TATA-box binding (Kotani et al., 2000) . It appears reasonable to assume that Ino2 TAD1 may also fulfil this function by binding to Taf1 aa 1-100 [activator binding domain 1 (ABD1) in Fig. 5 ]. Importantly, length variants of Taf1 devoid of ABD1 were still able to bind to Ino2 TAD1. This finding allowed us to identify ABD2 within Taf1 (aa 182-250), mapping to sequences which were previously considered as important for interaction with other Taf proteins.
A sequence alignment of Taf1 ABD2 among Saccharomyces yeasts showed a strong conservation especially of basic and hydrophobic amino acids (cf. Supporting Information, Fig. S1 ). Within ABD2, basic amino acids are clearly more abundant than acidic amino acids (16 K/R vs. 8 D/E). To investigate the functional importance of selected residues, mutant variants of ABD2 were constructed and compared for their Length variants of Ino2 were fused with GST, immobilized on GSH sepharose and incubated with yeast protein extracts containing HA-Taf fusions. Bacterial expression plasmids pSS56 (aa 1-304), pWTH12 (aa 1-135), pWTH11 (aa 135-304), pSH117 (aa 1-35) and pSH118 (aa 101-135) were used to synthesize various GST-Ino2 fusion proteins. Yeast expression plasmids pLvD1 (TAF1 1-250 ), pMS1 (TAF4), pEW1 (TAF6), pMS3 (TAF10) and pMS4 (TAF12) were transformed into strain C13-ABY.S86 which was subsequently used to prepare protein extracts. The reason for using truncated Taf1 (aa 1-250) is apparent from GST fusions of wild-type Ino2 (1-35) comprising TAD1 (pSH117) and its mutational derivatives D20K (pSH122) or F21R (pSH123) were incubated with yeast protein extracts containing HA-Taf fusions encoded by expression plasmids pLvD1 (TAF1 1-250 ), pMS1 (TAF4), pEW1 (TAF6), pMS3 (TAF10) and pMS4 (TAF12). GSTIno2 TAD1 wild-type and mutant variants could be synthesized, bound to GSH sepharose and eluted by free GSH with similar efficiencies (Supporting Information; Fig. S4 ).
binding to Ino2 TAD1 with respect to wild-type ABD2. Using site-directed mutagenesis, we generated double and triple mutations of amino acids K206 Y207, L208 L209 K210 and D215 E217 all of which were replaced by alanine residues. Three epitope-tagged mutant variants of ABD2 could be stably synthesized in E. coli and were subsequently used for binding studies with immobilized Ino2 TAD1. In contrast to wild-type ABD2, mutants K206A Y207A and L208A L209A K210A could no longer interact with TAD1 while interaction was still observed when acidic residues were affected (D215A E217A; cf. Fig. 6B ). These results are in agreement with the hypothesis that basic and hydrophobic amino acids are functionally important to establish TADTaf1 interaction.
Loss of Ino2-Taf1 ABD2 interaction in vitro may also affect activation of Ino2-dependent target genes in vivo. We, thus, constructed a plasmid containing a mutant of TAF1 which encodes the full-length Taf1 variant K206A Y207A. Using the plasmid shuffling strategy, this plasmid was used to replace the chromosomal wild-type copy of TAF1. Although the modified strain could grow normally in the absence of inositol (cf. Supporting Information, Fig. S5 ), activation of an INO1-lacZ reporter gene was significantly reduced (to 44% of the wild-type level; Fig. 7) . Komarnitsky et al. (1998) have shown that the major activation domain of glucose-regulated activator Adr1 (TAD4, aa 642-705) is able to contact TFIID subunits Taf1, Taf5, Taf6 and TBP. However, interacting domains of Taf proteins have not been mapped. We, thus, wished to investigate whether Ino2 TAD1 and Adr1 TAD4 contact identical or distinct domains of Taf1. The sequence encoding TAD4 of Adr1 was amplified by PCR, fused to GST and subsequently incubated with epitope-tagged length variants of Taf1 aa 1-250 (ABD1 1 ABD2), aa 1-137 (ABD1) and aa 182-250 (ABD2). To confirm TBP-Taf1 TAND interaction, a GSTSpt15 fusion (encoding full-length TBP) was also used for binding studies. As expected, length variants of Taf1 containing TAND sequences were indeed bound by TBP while ABD2 of Taf1 could not interact with TBP ( Fig. 6A ). As is also apparent from Fig. 6A , TAD1 of Ino2 and TAD4 of Adr1 both bind to ABD1 and ABD2, arguing for an identical pattern of interaction with Taf1 domains. This conclusion is further supported by the finding that missense mutations within ABD2 which abolished interaction with TAD1 of Ino2 (K206A Y207A and L208A L209A K210A) similarly affected the binding of Adr1 TAD4 (shown in Fig. 6B ).
Identification of activator binding domains within Taf6, Taf10 and Taf12
Similar to mapping studies leading to identification of ABD1 and ABD2 within Taf1 we also wished to define minimal domains of Taf6, Taf10 and Taf12 necessary for interaction with TAD1 of Ino2. For Taf4 we could show that an internal domain which was essential for binding to the TAD of Rap1 (aa 253-344) (Layer et al., 2010) is also able to interact with Ino2 TAD1 (M. Grigat, unpublished) .
A length variant representing the N-terminal part of Taf6 (comprising its histone-fold domain, HFD) could be GST fusion of wild-type Ino2 (1-35) comprising TAD1 (pSH117) was incubated with protein extracts from yeast (Sc) or E. coli (Ec) containing HA-Taf1 fusions encoded by expression plasmids pSH108 (aa 1-600), pSH110 (aa 1-450), pLvD1 (aa 1-250), pLvD6 (aa 1-137), pSH172 (aa 1-100), pSH184 (aa 350-1066), pLvD15 (aa 182-468) and pLvD22 (aa 182-250). As negative controls, interaction experiments were performed with GST lacking a fusion domain (not shown). Functional domains within Taf1: TAND1, 2 and 3 (Taf1 N-terminal domains: aa 10-37, aa 46-71 and aa 82-137) (Takahata et al., 2003) , Taf-Taf (domain for interaction with other Taf subunits of TFIID) (Bai et al., 1997) , HAT (histone acetyltransferase domain, aa 354-817) (Mizzen et al., 1996) , WH (winged helix DNA-binding domain) (Wang et al., 2014) , DBD (DNA-binding domain required for promoter binding) (Mencia and Struhl, 2001 ) and ABD1 and ABD2 (activator binding domains; this work).
stably synthesized in S. cerevisiae and was able to bind to GST-Ino2 TAD1. In contrast, no interaction was detected with the C-terminus of Taf6, containing most of its HEAT repeats (Fig. 8A) . Unfortunately, additional expression constructs designed for a more precise mapping of the Taf6 TAD interacting domain did not allow biosynthesis of more truncated protein fragments, neither in S. cerevisiae nor in E. coli.
To circumvent similar expression problems in future studies, we decided to construct GST fusions for length variants of Taf10 and Taf12 and used HA-tagged Ino2 (aa 1-135, comprising TAD1 and TAD2) for binding assays, thus, using an inverted relation of bait and prey proteins. GST-Taf10 (full-length) was able to interact with Ino2 TADs (Fig. 8B) , confirming results depicted in Figs 1 and 2. Interestingly, nonoverlapping sequences of Taf10 (aa 1-100 and aa 101-206) each fused with GST could bind to Ino2 TADs. Interaction was also observed with more truncated variants (aa 131-206 and aa 131-176 (Fig. 8B) , both representing sequences of the Taf10 histone-fold domain.
Taf12 may be considered as a frequently contacted coactivator subunit of TFIID because previous work led to its identification as an interaction partner of TADs from Gal4, Gcn4 and Rap1 (Fishburn et al., 2005; Reeves and Hahn, 2005; Garbett et al., 2007) . Using the same strategy as described for Taf10, bacterial expression plasmids were constructed which allowed the biosynthesis of length variants of Taf12, fused to S. cerevisiae strains MSY5C and MSY5D contain single-copy LEU2 plasmids pSH191 (TAF1) and pMS109 (TAF1   K206A Y207A ), respectively, complementing the chromosomal taf1D::HIS3 null allele. Similarly, in strains MSY6C and MSY6D, in the chromosomal taf12D::HIS3 null allele is complemented by plasmids pMS126 (TAF12) and pMS127 (TAF12, aa 279-539), respectively. Strains were transformed with reporter plasmid pJS325 (INO1-lacZ) and grown in selective medium (SCD-Ura-Leu) under inositol-limiting conditions (derepression). Specific b-galactosidase activities are given in nmol oNPG hydrolysed min 21 mg 21 protein.
GST. As shown in Fig. 9A , interaction with TADs of Ino2 is mediated by the N-terminus of Taf12 (aa 1-253) while its C-terminus containing a histone-fold domain did not bind (aa 254-539) . Similar to what was found with Taf1, Taf12 (aa 1-253) could be finally divided into smaller nonoverlapping regions each of which were able to interact with Ino2 TADs, defining activator binding domains ABD1 (aa 1-100) and ABD2 (aa 100-178). As a control, GST-Taf12 fusions representing core sequences of ABD1 and ABD2 were also incubated with extracts containing HA-Ino2 (1-135) but mutated at two residues essential for function of TAD1 (D20K F21R; see above). However, the remaining intact TAD2 was unable to interact with Taf12 (Fig. 9A) , confirming a previous experiment (cf. Fig. 3 ).
For a more precise characterization by site-directed mutagenesis we focused on ABD2 of Taf12 which shows a strong degree of sequence conservation among Saccharomyces yeasts (Supporting Information, Fig. S3 ) while ABD1 is considerably less conserved. We selected 10 conserved dipeptide sequences within ABD2 mostly containing basic and/or hydrophobic residues and replaced them by alanine (Fig. 9B) . The resulting GST-Taf12(ABD2) fusion variants were subsequently assayed for interaction with Ino2 TADs. Although the efficiency of interaction was significantly weakened for some dipeptide variants (T125A R126A; K131A F132A; I136A K137A; K150A L151A and R175A L176A), none of them showed a complete loss of binding (Fig. 9C) . Assuming that some functional redundancy among Taf12 residues may explain this result we finally combined two dipeptide variants (K150A L151A R175A L176A). Indeed, with this variant binding to Ino2 TADs was almost completely abolished. Results of mutational studies with Taf12 ABD2 are in agreement with conclusions derived from analysis of Taf1 ABD2, both emphasizing the importance of basic and hydrophobic amino acids for efficient activator-Taf interaction.
Similar to our characterization of a TAF1 ABD2 missense variant defective for interaction with Ino2 we also studied the influence of Taf12 ABD1 and ABD2 for activation of INO1. Although TAF12 is an essential gene, sequences encoding the N-terminus of the protein are not required for viability (Moqtaderi et al., 1996) . We, thus, compared activation of an INO1-lacZ reporter gene in the presence of a TAF12 full-length allele and a deletion variant lacking sequences which encode aa 1-278 (comprising ABD1 and ABD2). We could confirm that TAF12 (aa 279-539) is fully functional and allows growth in the absence of inositol (Supporting Information, Fig. S5 ). Expression of INO1 was only slightly reduced in the presence of this truncated allele (76% of the wild-type level; Fig. 7 ), indicating that TAF12 is less important for gene activation in vivo than TAF1.
Ino2-dependent recruitment of Taf1 and Taf6 to ICRE-containing promoters
Interaction of Ino2 TADs with TFIID subunits suggest that Taf proteins are recruited to promoter regions which require Ino2 for activation. To confirm Ino2-dependent occupation of ICRE-containing promoters by Taf proteins in vivo, we performed chromatin immunoprecipitation (ChIP) experiments in strains with epitope-tagged Taf1 and Taf6, respectively. Strains were cultivated with limiting supply of inositol and choline (derepressing conditions), thus, requiring activation of genes of phospholipid biosynthesis. Promoters of INO1 and CHO2 both contain three ICRE motifs and were chosen for analysis of immunoprecipitates by PCR, using gene-specific primers. As is shown in Fig. 10A (end-point PCR) and B (real-time PCR), Taf1 could be detected upstream of INO1 and CHO2 in a wild-type strain but not in an ino2 null mutant, confirming Ino2-dependent recruitment of Taf1. The same conclusion is true for Taf6, as demonstrated by ChIP experiments using epitope-tagged Taf6 A. GST fusion of wild-type Ino2 (1-35) comprising TAD1 (pSH117) was incubated with protein extracts from yeast (Sc) or E. coli (Ec) containing HA-Taf6 length variants encoded by expression plasmids pEW1 (aa 1-516), pEW7 (aa 1-263) and pEW8 (aa 264-516). HFD, histone-fold domain (aa 8-74); Taf6M, Taf6C, conserved domains of Taf6 protein (Scheer et al., 2012) . Taf6C contains five pairs of a-helical regions (HEAT domains). B. GST fusions containing Taf10 length variants were incubated with protein extract from E. coli transformed with expression plasmid pSH148 which encodes HA-Ino2(1-135). To synthesize GST-Taf10 fusions, plasmids pMS23 (aa 1-206), pMS14 (aa 1-107), pMS15 (aa 101-206), pMS22 (aa 131-206), pMS24 and pMS33 (aa 131-176) were used. GST activities in bacterial extracts were assayed and used to normalize for similar amounts of GSTTaf10 fusions. The position of the Taf10 histone-fold domain (aa 74-206) was described by Gangloff et al. (2001b) . A. GST fusions containing Taf12 length variants were incubated with protein extract from E. coli transformed with expression plasmid pSH148 which encodes HA-Ino2(1-135). To synthesize GST-Taf12 fusions, plasmids pMS12 (aa 1-539), pMS9 (aa 1-253), pMS19 (aa 254-539), pMS10 (aa 1-178), pMS18 (aa 1-100), pMS31 (aa 1-50), pMS30 (aa 50-100), pMS13 (aa 100-253), pMS34 (aa 179-253), pMS16 (aa 100-178) and pMS17 (aa 100-150) were used. GST-Taf12 fusions (aa 1-100) and (aa 100-178) comprising ABD1 and ABD2, respectively, were also used for interaction experiments with a mutant variant of pSH148 (pSH148mTAD1) encoding a defective TAD1 (D20K F21R) but a functional TAD2. The position of the Taf12 histone-fold domain (aa 414-490) was described by Gangloff et al. (2000) . ABD1, ABD2, activator binding domains. B. Sequence of Taf12 activator binding domain 2. Amino acid residues selected for mutagenesis are underlined. C. GST fusions containing mutant variants of Taf12 ABD2 (aa 100-178) were incubated with protein extract from E. coli transformed with expression plasmid pSH148 which encodes HA-Ino2(1-135). 111, strong interaction; 11, 1, weakened but evident interaction; -, no interaction. (contains a His-tagged variant of TAF1 at its natural chromosomal position) and HSY13 (isogenic ino2 deletion mutant). C, D. Analysis of strains HSY12 (contains a His-tagged variant of TAF6 at its natural chromosomal position) and HSY15 (isogenic ino2 deletion mutant). Promoter fragments were analyzed by end-point PCR (A, C) and real-time PCR (B, D) using specific primers for INO1, CHO2 and ACT1 (negative control). Ct values obtained for samples of the ino2 mutants refer to wild-type samples which were set to 1. IN, input control of total chromatin fragments; IP, analysis of samples obtained by affinity purification.
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in wild-type and ino2 strains ( Fig. 10C and D) . Thus, Ino2 not only interacts with various Taf proteins in vitro but is also required for in vivo presence of Tafs at promoters of phospholipid biosynthetic genes.
Functional Taf proteins are required for transcription of INO1
Although genes which encode subunits of TFIID are essential for viability, not all yeast promoters depend on Taf proteins (TAF dep vs. TAF ind promoters, dependent vs. independent) (Li et al., 2000) . Results described so far allow the conclusion that activation of ICREcontaining genes should require functional Tafs. To confirm this assumption we, thus, performed Northern blot hybridizations, comparing transcription of INO1 in a wild-type strain and conditional mutants of taf1 and taf6 at 308C or 378C (nonpermissive temperature). As a control, we used the glycolytic gene PGK1. Although considered as a typical house-keeping gene, PGK1 has been described as expressed independently of Taf proteins but dependent on SAGA (Li et al., 2000; Huisinga and Pugh, 2004) . Indeed, transcription of PGK1 was almost unaffected in taf1 ts and taf6 ts mutants after 60 min at 378C (Fig. 11) . In contrast, the amount of INO1 mRNA in taf ts mutants was strongly reduced following cultivation under nonpermissive conditions, demonstrating that functional Taf proteins are indispensable for continued transcriptional activation of the Ino2-and ICRE-dependent INO1 gene.
Discussion
Transcriptional activation domains (TADs) of intensively studied activators such as Gal4, Gcn4 and VP16 are able to contact several target proteins (coactivators) which may be subunits of distinct complexes (summarized by Bhaumik, 2011) , indicating some functional redundancy among interactions required for stimulation of gene expression. Since control regions of strongly expressed genes usually contain more than a single UAS element, promoter occupancy by several activator proteins and subsequent recruitment of different coactivator complexes would allow synergistic gene activation (Carey et al., 1990) . In this work, we show that activator Ino2 responsible for transcription of yeast genes of phospholipid biosynthesis is able to directly contact subunits Taf1, Taf4, Taf6, Taf10 and Taf12 of the general transcription factor TFIID via its TAD1 and/or TAD2. Importantly, TAD1 (which is substantially more efficient than TAD2; Dietz et al., 2003) interacts with all of these five Tafs while TAD2 could merely bind Taf10, suggesting that the efficiency of a TAD may depend on the number of its interaction partners. In addition to Taf10, TAD2 of Ino2 also interacts with pleiotropic corepressors Sin3 and Cyc8, indicating that these corepressors can mediate positive effects and explaining why null mutants sin3 and cyc8 are compromised for repression as well as for maximum activation of ICRE-dependent genes (Kliewe et al., 2017) . Our initial screen for Taf proteins binding to Ino2 in vitro used yeast protein extracts and gave evidence for interaction of Ino2 with Taf1, Taf4, Taf5, Taf6, Taf10 and Taf12. With the exception of Taf5, all binding partners of Ino2 were confirmed using bacterially synthesized Taf proteins. Interaction studies with length variants of Taf5 which could be stably synthesized in yeast revealed that indirect binding is mediated by its C-terminus, comprising 6 WD40 repeats (results not shown). We suggest that indirect Ino2-Taf5 interaction can be explained by direct binding of Ino2 to a Taf protein which also contacts WD40 repeats of Taf5. Biosynthesis of Taf5 together with histone-fold domain containing Taf4/12, Fig. 11 . Influence of conditional taf mutants on transcript amounts. Strains WCS188 (wild-type), YSW93 (taf1 ts ) and YSB552 (taf6 ts ) were cultivated in synthetic complete medium with limiting concentrations of inositol and choline (derepressing conditions) at 308C. Cultures were harvested in the early exponential growth phase (308C samples) or transferred to fresh medium and incubated for additional 1 h (378C samples, nonpermissive conditions). Total RNA was prepared from cells, separated by electrophoresis under denaturing conditions, transferred to a membrane and hybridized against probes for INO1 and PGK1, respectively. As a loading control, total RNA was visualized by treatment of a membrane with methylene blue. Digital signals were corrected by background subtraction. Relative signal intensities of 378C samples refer to 308C samples which were set to 100. Taf6/9 and Taf8/10 in insect cells allowed detection of a stable TFIID subcomplex (Leurent et al., 2004) Previously performed comprehensive gene classifications came to the conclusion that genes regulated by nutrient supply mainly contain TATA consensus sequences and are dependent on the histone acetyltransferase complex SAGA (about 10% of all yeast genes) while TFIID-dependent genes represent basic cellular functions and are devoid of strong TATA elements (90%) (Basehoar et al., 2004; Huisinga and Pugh, 2004) . Thus, the Taf-dependent gene INO1 which contains a TATA box consensus sequence (TATATAAA at -123/-116) and is strongly regulated by the availability of inositol means an exception to this classification, similar to the phosphate-regulated PHO5 gene (Huisinga and Pugh, 2004) .
To promote dynamic formation of transcriptional preinitiation complexes, activation domains must establish low-affinity and transient coactivator interactions. Although various TADs do not exhibit an obvious pattern of sequence similarity, certain residues of defined biochemical quality appear to be critical for activation function. Initially, a cluster of acidic amino acids was considered as decisive for activation (e.g., in the case of Gcn4 and Gal4) (Hope and Struhl, 1986 ; summarized by Sigler, 1988) while later studies showed the importance of bulky hydrophobic residues with an emphasis on the aromatic amino acid phenylalanine (analyses of Gcn4, VP16 and p53 TADs) (Cress and Triezenberg, 1991; Drysdale et al., 1995; Sullivan et al., 1998; Uesugi and Verdine, 1999) . More recently, a nine amino acid core motif present in more than 40 activators from yeast to mammals has been proposed (Piskacek et al., 2016 ; minimal TAD of Gal4: DDVYNYLFD; aa 862-870). Within TAD1 of Ino2 (aa 1-35), aa 18-28 (DIDFE-TAYQML) show almost complete sequence conservation among yeast orthologues, indicating functional importance. Indeed, mutational analysis of selected amino acids within this region confirmed that F21 could not be replaced without severe loss of activation while substitution of D20 and E22 against some hydrophobic residues was tolerated (Dietz et al., 2003) . As shown in this work, Taf proteins which can bind to wild-type TAD1 of Ino2 uniformly fail to interact with mutants lacking hydrophobic (F21) or acidic (D20) residues at defined positions, providing a possible explanation why these variants of TAD1 are defective for activation.
For a better understanding of TAD-coactivator interactions it is necessary to identify minimal activator binding domains (ABDs) and their structural features. Detailed mapping studies have been previously performed for Gal11/Med15 which is an evolutionary conserved subunit of the tail module of the mediator complex (Park et al., 2000; Herbig et al., 2010; Jedidi et al., 2010) , demonstrating that three noncontiguous regions are able to contact Gcn4 TAD (activator binding domains ABD1-ABD3). Since TAD-coactivator interactions are weak, limited data on structural mechanisms of recognition are available. NMR studies in solution of VP16 and Gcn4 provided evidence that TADs form intrinsically disordered structures which adopt a defined helical conformation upon interaction with coactivator target proteins. As shown for Gal11/Med15 and human Taf9, hydrophobic contacts between TADs and coactivator domains are of central importance for the transition from random coil to an a-helix (Uesugi et al., 1997; Jonker et al., 2005; Brzovic et al., 2011) .
For a more precise understanding of Ino2-Taf interactions we used length variants of selected Taf proteins to map minimal domains required for binding to Ino2 TAD1. Results presented here and by others showed that some (Taf6, Taf10) but not all activator binding domains (Taf4, Layer et al., 2010; Taf12, Garbett et al., 2007, this work) overlap with histone-fold domains of Taf proteins. Truncated variants of Taf1 allowed us to identify two separate activator binding domains, ABD1 (aa Taf subunits of TFIID interact with Ino2 885 1-100) and ABD2 (aa 182-250). Binding of TAD1 of Ino2 to Taf1 ABD1 (which essentially comprises TAND subdomains of Taf1; TAF N-terminal domain) (Kokubo et al., 1998) may counteract inhibition of TBP by TAND as previously suggested for mammalian c-Jun which also interacts with the N-terminal region of human Taf1 (aa 1-163) (Lively et al., 2001) . Since ABD1/TAND of Taf1 binds to the concave and convex surfaces of TBP, recognition of the TATA box by TFIID is prevented in the absence of activators (Kotani et al., 2000) . Interaction of Ino2 TAD1 with ABD1/TAND may trigger a conformational alteration within TFIID and autoinhibition is relieved, stimulating recognition of basal promoter elements (Lively et al., 2001) . TAD4 of yeast activator Adr1 was also shown as an interaction partner of Taf1 but no mapping studies have been described (Komarnitsky et al., 1998) . In this work, we were able to confirm this finding and could further show that Ino2 TAD1 and Adr1 TAD4 display an apparent identical pattern of interaction with Taf1 (contact to ABD1 and ABD2). ABD2 is a newly described domain of Taf1 which shows considerable sequence conservation among Saccharomyces yeasts and is similar even to human Taf1 (Supporting Information, Fig. S2 ). As exemplified by the intensively investigated Gal11/Med15 protein, the existence of more than a single activator binding domain within a coactivator is not unusual (ABD1-ABD3) (Herbig et al., 2010; Jedidi et al., 2010) . Similar to Taf1, Taf12 also contains two ABDs at its N-terminus (ABD1, aa 1-100; ABD2, 100-178) both of which can bind TAD1 of Ino2, each in the absence of the other. Garbett et al. (2007) used serial truncations of Taf12 and demonstrated that aa 1-285 and aa 241-539 of Taf12 could interact with the TAD of Rap1, suggesting the existence of a third ABD which comprises aa 241-285. Interestingly, aa 1-225 of Taf12 were unable to bind Rap1 (Garbett et al., 2007) while aa 1-178 efficiently interact with TAD1 of Ino2.
Is TAD-coactivator interaction controlled by a strictly conserved binding pattern common to a large number of TADs or by individual recognition of targets? Although the number of yeast TADs systematically investigated for contacts to coactivators is still limited, some of them (the 'usual suspects', e.g., Gal11, Tra1 and Taf12) have been frequently identified as TAD binding partners. Nevertheless, most TADs show a specific combination of targets as is evident from TFIID-binding activators Rap1 (binds Taf4, Taf5 and Taf12) and Ino2 (binds Taf1, Taf4, Taf6, Taf10 and Taf12). As exemplified for TADs of Rap1 and Ino2, different ABDs of Taf12 may be contacted. The view that TADs exhibit target specificity is further supported by a structural study using cryo-EM, demonstrating individual regions of TFIID as contact sites for mammalian activators p53, Sp1 and c-Jun (Liu et al., 2009 ).
While TADs have been intensively studied by mutational analyses, much less is known about residues critical for coactivator function. Site-directed mutagenesis of conserved residues within ABD2 of Taf1 (aa 182-250) provided evidence that basic (K206A, K210A) and hydrophobic amino acids (L208A L209A) are crucial for TAD-ABD interactions (shown here at least for Ino2 and Adr1). This agrees with results obtained for ABD1 of Gal11 where mutation W196A completely abolished binding to the central TAD of Gcn4 while M213A led to a substantially weakened interaction (Brzovic et al., 2011) . The single ABD within Taf4 (aa 253-344) which is extremely conserved among Saccharomyces yeasts and was initially identified as necessary for interaction with Rap1 (Layer et al., 2010) is also sufficient for binding to TADs of Ino2. Using error-prone PCR, Layer et al. isolated variants of TAF4 encoding temperature-sensitive proteins which showed reduced affinity for Rap1. However, proteins characterized in this mutant screen contained changes at several positions and affected amino acids of unrelated biochemical properties. In this work, we report comparative investigations with mutant variants of Taf12 ABD2 in which conserved pairs of basic and hydrophobic amino acids have been replaced. Binding assays showed that interaction of such variants with Ino2 TAD1 is weakened but not completely abrogated, indicative of redundant TAD-coactivator contacts. This assumption is supported by our finding that combining two of these mutant dipeptides (K150A L151A R175A L176A variant) almost completely prevented interaction. In summary, these results show that a rational (hypothesis-driven) design of mutations within ABDs allows the identification of variants showing complete or partial loss of function and emphasizes the importance of basic and hydrophobic amino acids to establish interaction with TADs.
Experimental procedures
Yeast strains, media and growth conditions For preparation of protein extracts from Saccharomyces cerevisiae, transformants of strain C13-ABY.S86 lacking four vacuolar proteinases (pra1 prb1 prc1 cps1) (De Antoni and Gallwitz, 2000) were used. This strain was also used to replace authentic TAF genes by epitope-tagged variants which were required for ChIP analyses (see below). Isogenic ino2 null mutants were obtained by transformation with disruption plasmid pSS29 (Dino2::HIS3) (Schwank et al., 1995) . Strains YSW93 (taf1 ts ) and YSB552 (taf6 ts ) have been described (Shen et al., 2003) . All strains of S. cerevisiae used in this work and their complete genotypes are available as Supporting Information (Table S1 ). Procedures of yeast transformation and selection for transformants on synthetic complete media have been previously described (Schwank et al., 1995) .
Plasmid constructions
To synthesize GST fusion proteins in E. coli, expression plasmids derived from pGEX-2TK (tac promoter upstream of the glutathione S-transferase gene GST; GE Healthcare) were used. Using chromosomal wild-type DNA as a template, entire or truncated coding regions of INO2, ADR1, SPT15, TAF10 and TAF12 were PCR amplified and fused behind GST. Yeast expression plasmids encoding HA-tagged variants of Taf proteins were derived from p425-MET25HA or p426-MET25HA (Mumberg et al., 1994) . For bacterial synthesis of epitope-tagged proteins, a variant of expression plasmid pASK-IBA5 (tet promoter/operator, followed by three repeats encoding HA; IBA G€ ottingen, Germany) was used. Inserts containing complete or truncated coding regions of INO2 and 14 TAF genes were amplified by PCR, using gene-specific oligonucleotide primers. To confirm authenticity of gene fragments obtained by PCR, fusion constructs representing the minimal length required for interaction of Taf proteins with a partner protein were verified by DNA sequencing (LGC Genomics, Berlin, Germany). Plasmid names and relevant insert sequences are mentioned in legends of figures and are described in detail as Supporting Information (Table S2) . Primers used for amplification of gene-specific sequences by PCR are also shown as Supporting Information (Table S3) .
Site-directed mutagenesis
To introduce missense mutations into INO2, TAF1 and TAF12, the QuikChange site-directed mutagenesis kit from Agilent/Stratagene was used. Pairs of mutagenic primers were designed which allowed replacement of the natural codon at a defined position against an alanine-specific codon (for sequence details see Supporting Information, Table S3 ). For primer-dependent introduction of mutations into wild-type templates, plasmids pSH117 [GST-INO2 (aa 1-35)], pLvD22 [HA 3 -TAF1 (aa 182-250)] and pMS16 [GST-TAF12 (aa 100-178)] were used. The successful construction of the desired variants and the absence of unwanted alterations were confirmed by DNA sequencing of mutant plasmids (LGC Genomics).
Plasmid shuffling
Functional analysis of variants of TAF1 and TAF12 followed the plasmid shuffling strategy described by Sikorski and Boeke (1991) . The entire TAF1 gene (together with its native promoter and terminator) was PCR amplified and inserted into ARS CEN URA3 vector pRS416 (Agilent/Stratagene). The resulting plasmid pGE3 was transformed into wild-type strain JS91.15-23 (Schwank et al., 1995) . To remove the chromosomal copy of TAF1, gene disruption plasmid pGE2 (taf1D::HIS3) which allows deletion of 155/ 12045 was used. With the resulting strain MSY5B, plasmid shuffling was performed using ARS CEN LEU2 plasmids pSH191 (TAF1) and pMS109 (TAF1 K206A Y207A ) both of which were derived from YCplac111 (Gietz and Sugino, 1988) . The K206A Y207A mutation of pMS109 was introduced into an internal BamHI 1 XbaI fragment of TAF1 as described above and transferred back into TAF1 after verification of the desired mutation by DNA sequencing. Incubation on synthetic medium containing 5-fluoroorotic acid (FOA) allowed counter-selection against pGE3 and phenotypic characterization of the resulting strains MSY5C (taf1D TAF1) and MSY5D (taf1D TAF1 K206A Y207A ), respectively. Similarly, plasmid shuffling was performed with TAF12 variants. TAF12 (together with 585 bp of its promoter and 150 bp of terminator sequence) was PCR amplified and inserted into pRS416. After transformation of the resulting plasmid pMS124 into strain JS91.15-23, the chromosomal TAF12 copy was removed using gene disruption plasmid pMS129 (taf12D::HIS3, allows deletion of 181/11464). For plasmid shuffling, the resulting strain MSY6B was transformed with plasmids pMS126 (TAF12) and pMS127 (TAF12 aa 279-539 ) derived from YCplac111. To obtain the TAF12 variant lacking ABD1 and ABD2, the TAF12 promoter was fused with a truncated reading frame containing an artificial start codon which was placed before codon 279. Selection on FOA-containing medium allowed loss of pMS124 and phenotypic characterization of the resulting strains MSY6C (taf12D TAF12) and MSY6D (taf12D TAF12 aa 279-539 ), respectively.
In vitro-interaction assays E. coli strain BL21 (Stratagene/Agilent) was transformed with bacterial expression plasmids and subsequently used for biosynthesis of GST-and HA-tagged proteins. Gene expression activated by promoters tac (controlling GST fusion genes) and tet (controlling HA fusion genes) was induced with 1 mM IPTG and 0.2 mg/l anhydrotetracycline, respectively. To produce HA-tagged proteins in S. cerevisiae, strain C13-ABY.S86 was transformed with expression plasmids containing MET25-activated gene fusions and cultivated in the absence of methionine.
To perform in vitro-interaction assays by affinity chromatography, induced E. coli cells were disrupted by sonication. Yeast transformants were broken by intensive agitation with zirconia beads (0.7 mm). Following immobilization of GST fusion proteins on glutathione (GSH) sepharose, total yeast or E. coli protein extracts containing HA fusions were added and incubated overnight. Unbound proteins were removed by repeated washing as previously described (intermediary stringency) (Wagner et al., 2001) . GST fusions together with interacting HA-tagged proteins were eluted from GSH sepharose by adding free GSH (10 mM), subsequently separated by SDS/PAGE and transferred to a filter. HA fusion proteins were detected by treatment of the filter with anti-HA-peroxidase conjugate (Roche Biochemicals). After incubation of the filter with luminol and H 2 O 2 , chemiluminescent signals were visualized on x-ray films. Routinely, input controls contain 50 mg of total protein, representing 20% of the amount used for interaction experiments.
Chromatin immunoprecipitation
ChIP was performed as previously described (Grigat et al. 2012) . TAF1 and TAF6 were modified at their natural chromosomal positions such that they express His-tagged Taf1
Taf subunits of TFIID interact with Ino2 887 and Taf6 without alteration of the respective gene control region. Replacement fragments were amplified by PCR, using plasmid pU6H3HA as a template (contains a His 6 -HA 3 -kanMX cassette) (De Antoni and Gallwitz, 2000) and primers specific for TAF1 or TAF6. Gene-specific replacement fragments were transformed into strain C13-ABY.S86, selecting for resistance against geneticin. The desired chromosomal alterations were verified by PCR, using TAF-und kanMX-specific primers. Biosynthesis of epitope-tagged Taf proteins in the resulting strains HSY10 (TAF1-His 6 -HA 3 ) and HSY12 (TAF6-His 6 -HA 3 ) and their corresponding ino2 derivatives HSY13 and HSY15 (cf. Supporting Information, Table S1 ) was confirmed by Western Blot analysis of crude protein extracts, using an anti-HA-peroxidase conjugate.
Strains were grown until mid-log phase and treated with formaldehyde for 15 min (final concentration: 1%) to crosslink proteins and DNA. The crosslinking reaction was quenched by addition of glycine (final concentration: 125 mM, 5 min) and cells were lysed and sonicated 5 times for 30 s to shear chromatin (Bandelin Sonoplus UW 70 microtip, 35% power). After removal of insoluble material by centrifugation, the supernatant was incubated with His-Tag DynabeadsV R (Invitrogen/DynalV R ) for at least 4 h. Dynabeads were intensively washed and affinity-bound proteins and DNA were eluted with a buffer containing 300 mM imidazole. To reverse crosslinking, samples were heated to 658C overnight and proteins were degraded by treatment with proteinase K. DNA was concentrated by precipitation and finally analyzed by endpoint-PCR (27 amplification cycles) and real-time PCR, using specific primers against promoters of INO1 (-363/124) and CHO2 (-360/124) or gene ACT1 (1781/11165) as a control. 5% of cell lysates used for immunoprecipitation were analysed as input control. For a quantitative PCR analysis of DNA fragments, the Applied Biosystems StepOnePlus Real-Time PCR system (AB Germany, Darmstadt) together with the Power SYBRV R Green PCR Master Mix was used. Normalized Ct values obtained with immunoprecipitates were corrected for Ct values of the negative control (ACT1). Corrected Ct values of mutant samples (HSY13 and HSY15) refer to corresponding wild-type samples (HSY10 and HSY12) which were set to 1.
Transcript analysis by northern blot hybridization
For RNA preparation, strains WCS188, YSW93 and YSB552 were grown in synthetic medium with limiting concentrations of inositol (5 lM) and choline (50 lM) at 308C until early log phase. Cultures were split into two samples, quickly harvested by centrifugation and stored at 2708C or resuspended in fresh medium prewarmed to 378C. After incubation at 378C for additional 60 min, cells of this sample were also harvested and stored at 2708C.
RNA from cell samples was isolated using the MasterPure TM Yeast RNA Purification Kit according to recommendations of the manufacturer (EpicentreV R /Illumina; Biozym/ Germany). Three mg of total RNA was separated in a vertical agarose gel (1.2%) under denaturing conditions (2.2 M formaldehyde), subsequently transferred to a nylon membrane by vacuum blotting and finally crosslinked to the membrane by UV irradiation. RNA hybridization probes for detection of INO1 and PGK1 transcripts were labelled with digoxigenin (DIG) by in vitro-transcription of PCR-amplified fragments as templates, using DIG-UTP and T7 RNA polymerase from the DIG-RNA labelling kit (Roche Applied Science). RNA-RNA hybridization was performed under stringent conditions (688C) as previously described (Sch€ uller et al., 1992b) . To detect DIG-labelled RNAs, the anti-Digoxigenin-AP Fab fragment (conjugated with alkaline phosphatase) together with the reagent CDP-Star (Roche) was used. Chemiluminescent signals were visualized and quantified with a Chemocam Imager (INTAS; G€ ottingen, Germany), using the software ImageQuant TL (GE Healthcare).
